ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Wellbutrin XR 150 mg, Retardtabletten - 30 Tablette(n)
57803004 GlaxoSmithKline AG
Wellbutrin XR 150 mg, Retardtabletten01.11.2007
Original01.11.2007
Bupropion (N06AX12) 
WHO-DDD 
01.06.30 Tablette(n)
01.06. 
B  
Yes 
IPCI
14.05Yes
    
10 %31.60
7680578030048Synthetika
3619102 
Composition
bupropioni hydrochloridum 150 mg, poly(alcohol vinylicus), glyceroli dibehenas, Überzug: ethylcellulosum, povidonum K 90, macrogolum 1450, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, silica colloidalis hydrica, triethylis citras, Drucktinte: lacca, E 172 (nigrum), ammonii hydroxidum, pro compresso obducto.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Bupropion Hydrochloride150 mg
BAG: Active AgentDose
Bupropion Hydrochloride150 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
Acidi Methacrylici  
Ammonii Hydroxidum  
E 172 color.
Ethylcellulosum Überzug
Ethylis Acrylatis Polymerisatum  
Glyceroli Dibehenas  
Lacca Drucktinte
Macrogol1450  
Poly(Alcohol Vinylicus)  
Povidonum K90  
Pro Compresso Obducto  
Silica Colloidalis Hydrica  
Triethylis Citras  
 
Source
Data was imported : 06.12.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home